Reliance Industries Q4 Results Live Updates: The Nifty 50 heavyweight Reliance Industries Ltd. (RIL) is set to report its fourth quarter earnings post market hours today. A CNBC-TV18 poll has estimated the Mukesh Ambani-led conglomerate’s revenue to increase by 3%…
Five9, Meta Platforms and Wingstop have strong records of beating earnings and post report gains, despite recent share declines, with analysts seeing major upside ahead
UTI Asset Management Company reported a net loss for the quarter and that the fall seen by the stock today is the most it has seen since its listing back in 2020.
Mark Matthews, Bank Julius Baer & Co, said India’s economy can withstand higher crude, but investor sentiment may weaken if prices remain elevated. He highlighted midcap resilience as a lead signal for broader markets, while noting that prolonged energy disruptions…
Another note from Citi said that while revenue for Dr. Reddy’s in the current financial year could reach between $80 million to $100 million in a three-player market, with a mandatory generic discount of 65%, a significant upside towards $150…
USFDA has issued an import alert on the Rodopi unit in Greece operated by Pharmathen, which supplies Lanreotide injection to Cipla. Lanreotide is among Cipla’s top three products in the US market and commands a market share of around 22%.
Q4 Results LIVE Updates: The first earnings-heavy week will culminate with Nifty 50 heavyweight Reliance Industries reporting its results post market hours today. Along with Reliance Industries, Hindustan Zinc, Adani Green Energy, Can Fin Homes, Atul, Chennai Petro, IndusInd Bank,…
Lux Industries said the pursuant to the FSA and on recommendation of its audit committee, the revised brand licensing agreement is approved and executed between the firm and Biswanth Hosiery Mills Ltd. (BHML) to safeguard the company’s rights and obligations…
Muthoot FinCorp opens third secured NCD tranche to raise up to ₹600 crore, offering 8.84 to 9.25% yields, rated AA minus Positive and AA Stable, to be listed on BSE.
Under its ‘Lakshya 31’ strategy, LTIMindtree aims to double revenue over the next five years, with a mix of organic and inorganic expansion.